ABT-384

DRUG3 trials

Sponsors

Abbott, AbbVie (prior sponsor, Abbott)

Conditions

Alzheimer's DiseaseHealthy

Phase 1

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-384 in Elderly Subjects

CompletedNCT00968422

Start: 2009-08-31Updated: 2010-11-03

A Study of ABT-384 Levels and Pharmacodynamic Activity Measured in Cerebrospinal Fluid

CompletedNCT01009216

Start: 2009-10-31End: 2010-11-30Updated: 2010-12-14

Phase 2

Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease

CompletedNCT01137526

AbbVie (prior sponsor, Abbott)Alzheimer's Disease

Start: 2010-05-31End: 2011-07-31Updated: 2013-01-29